Shraddha Jatwani

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Zara Izadi, Erica J. Brenner, Satveer K. Mahil et al. · JAMA Network Open · 2021 · 116 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Value of Isolated IgA Anti–β₂‐Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome

Vijaya Murthy, Rohan Willis, Zurina Romay‐Penabad et al. · Arthritis & Rheumatism · 2013 · 109 citations · Full text

Life Sciences, Immunology, Pathology +16

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

Sebastian E. Sattui, Richard Conway, Michael Putman et al. · The Lancet Rheumatology · 2021 · 51 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

FRI0520 HOSPITALIZATIONS FOR HEMATOLOGICAL MALIGNANCIES WITH RHEUMATIC DISEASES: A NATIONAL INPATIENT SAMPLE ANALYSIS OF TEN YEARS (2005-2014)

Karan Jatwani, Karan Chugh, Irene Tan et al. · Annals of the Rheumatic Diseases · 2020 · 22 citations

Medicine, Hematology, Internal Medicine +12

Systemic Lupus Erythematosus Is Associated With a High Risk of Venous Thromboembolism in Hospitalized Patients Leading to Poor Outcomes and a Higher Cost: Results From Nationwide Inpatient Sample Database 2003‐2011

Shweta Kishore, Shraddha Jatwani, Bharat Malhotra et al. · ACR Open Rheumatology · 2019 · 21 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +15